|
ZFP14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.446700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.161400E-04 |
| Normal-vs-Stage2 |
2.569900E-02 |
| Normal-vs-Stage3 |
1.024170E-03 |
| Normal-vs-Stage4 |
1.651770E-02 |
| Stage1-vs-Stage2 |
9.602000E-01 |
| Stage1-vs-Stage3 |
4.747600E-01 |
| Stage1-vs-Stage4 |
7.800400E-01 |
| Stage2-vs-Stage3 |
5.297600E-01 |
| Stage2-vs-Stage4 |
7.620400E-01 |
| Stage3-vs-Stage4 |
8.453200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.536870E-03 |
| Normal-vs-AfricanAmerican |
1.021690E-02 |
| Normal-vs-Asian |
1.418500E-02 |
| Caucasian-vs-AfricanAmerican |
9.470000E-01 |
| Caucasian-vs-Asian |
5.252800E-01 |
| AfricanAmerican-vs-Asian |
4.706200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.422120E-04 |
| Normal-vs-Female |
2.148800E-01 |
| Male-vs-Female |
3.289600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.885700E-02 |
| Normal-vs-Extreme_Weight |
1.82184999999446E-05 |
| Normal-vs-Obese |
1.356790E-01 |
| Normal-vs-Extreme_Obese |
7.282900E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.047850E-01 |
| Normal_Weight-vs-Obese |
4.108600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.968800E-01 |
| Extreme_Weight-vs-Obese |
5.875800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.766400E-01 |
| Obese-vs-Extreme_Obese |
1.781760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.421700E-03 |
| Normal-vs-Age(41-60Yrs) |
7.785900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.165310E-04 |
| Normal-vs-Age(81-100Yrs) |
1.862550E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.535000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.792800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.433000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.301750E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.153050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.719200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.902400E-03 |
| Normal-VS-Type2 PRCC |
7.216000E-04 |
| Normal-VS-KIRP CIMP |
1.117140E-03 |
| Normal-VS-Unclassified PRCC |
1.575170E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.790000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.076810E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.805400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.717600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.520000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.693380E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.73550000000167E-05 |
| Normal-vs-N1 |
8.080000E-02 |
| Normal-vs-N2 |
1.403330E-03 |
| N0-vs-N1 |
1.045750E-01 |
| N0-vs-N2 |
2.388200E-01 |
| N1-vs-N2 |
1.130980E-01 |
|
|
